We are live on
!
Find out more
SCM
Suvretta Capital Management Portfolio holdings
AUM
$3.92B
1-Year Est. Return
86.67%
This Fund
S&P 500
This Quarter
Est. Return
+19.44%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$2.38B
AUM Growth
-$27.3M
(-1.1%)
Cap. Flow
-$219M
Cap. Flow
% of AUM
-9.21%
Top 10 Holdings %
Top 10 Hldgs %
39.28%
Holding
114
New
41
Increased
19
Reduced
15
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biohaven
BHVN
|
+$53.5M |
| 2 |
AT&T
T
|
+$52.8M |
| 3 |
Nike
NKE
|
+$50.1M |
| 4 |
Wynn Resorts
WYNN
|
+$50.1M |
| 5 |
Fidelity National Information Services
FIS
|
+$49.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.1M |
| 2 |
Walt Disney
DIS
|
+$87.4M |
| 3 |
Amazon
AMZN
|
+$82.9M |
| 4 |
IQVIA
IQV
|
+$71.9M |
| 5 |
Global Payments
GPN
|
+$71.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.26% |
| 2 | Consumer Discretionary | 16.29% |
| 3 | Industrials | 12.13% |
| 4 | Consumer Staples | 8.08% |
| 5 | Technology | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
PepGen
PEPG
$197M
| $11.1M | 0.47% |
828,087
-352,897
| -30% | -$4.56M |
|
52
Alvotech
ALVO
$1.29B
| $10M | 0.42% |
1,000,000
| – | – |
|
|
KALV
53
DELISTED
KalVista Pharmaceuticals
KALV
| $7.25M | 0.3% |
1,072,302
-634,798
| -37% | -$3.4M |
|
54
InflaRx
IFRX
$271M
| $6.65M | 0.28% |
2,146,240
| – | – |
|
|
VTYX
55
DELISTED
Ventyx Biosciences
VTYX
| $6.11M | 0.26% |
186,400
| – | – |
|
|
MREO
56
Mereo BioPharma
MREO
$47.3M
| $5.52M | 0.23% |
7,364,438
| – | – |
|
57
Johnson & Johnson
JNJ
$625B
| $5.17M | 0.22% |
+29,290
| New | +$5.06M |
|
58
BioNTech
BNTX
$23.5B
| $4.6M | 0.19% |
+30,600
| New | +$4.71M |
|
59
AtaiBeckley Inc
ATAI
$2.68B
| $4.36M | 0.18% |
1,637,960
+412,459
| +34% | +$1.25M |
|
60
Elanco Animal Health
ELAN
$11.1B
| $4.33M | 0.18% |
+354,400
| New | +$4.42M |
|
|
AKLI
61
DELISTED
Akili Inc
AKLI
| $4.06M | 0.17% |
3,624,163
| – | – |
|
|
MOLN
62
Molecular Partners
MOLN
| $2.62M | 0.11% |
400,000
| – | – |
|
|
LKFT
63
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
| $2.09M | 0.09% |
+47,200
| New | +$1.99M |
|
64
Natera
NTRA
$46.4B
| $2.08M | 0.09% |
+51,900
| New | +$2.14M |
|
65
Danaher
DHR
$144B
| $1.97M | 0.08% |
8,383
-246,705
| -97% | -$57.2M |
|
66
Thermo Fisher Scientific
TMO
$220B
| $1.85M | 0.08% |
3,360
-111,365
| -97% | -$59M |
|
67
Spyre Therapeutics
SYRE
$9.25B
| $1.83M | 0.08% |
162,396
| – | – |
|
68
Abbott
ABT
$187B
| $1.13M | 0.05% |
+10,310
| New | +$1.07M |
|
69
Sanofi
SNY
$104B
| $1.1M | 0.05% |
+22,610
| New | +$992K |
|
70
AstraZeneca
AZN
$250B
| $1.06M | 0.04% |
+7,845
| New | +$984K |
|
71
Medtronic
MDT
$112B
| $728K | 0.03% |
+9,366
| New | +$759K |
|
72
Boston Scientific
BSX
$71.5B
| $654K | 0.03% |
+14,141
| New | +$612K |
|
|
73
IQVIA
IQV
$39.3B
| $606K | 0.03% |
2,959
-354,726
| -99% | -$71.9M |
|
74
argenx
ARGX
$54.1B
| $576K | 0.02% |
+1,520
| New | +$569K |
|
75
Illumina
ILMN
$28.4B
| $568K | 0.02% |
+2,889
| New | +$599K |
|
Similar funds
MIM
BCP
AS
MSI
FLSM
LWCA
TFM
USCWA
Suvretta Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Suvretta Capital Management held 114 positions worth $2.38B, down 1.1% from $2.41B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Suvretta Capital Management withdrew a net $219M in Q4 2022, closing 25 positions and reducing 15 holdings. Its most notable exit was Microsoft, an estimated $89.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 45% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Suvretta Capital Management opened a new position in AT&T worth $54.3M.
- Suvretta Capital Management's largest Q4 2022 buy was AT&T: 2,951,900 shares worth $54.3M.
- Suvretta Capital Management added most to Biohaven in Q4 2022, an estimated $53.5M increase.
- Suvretta Capital Management's biggest Q4 2022 reduction was IQVIA, cutting an estimated $71.9M.
- Suvretta Capital Management fully exited Microsoft in Q4 2022, selling an estimated $89.1M.
- Suvretta Capital Management's ten largest holdings make up 39% of its $2.38B portfolio in Q4 2022.
- Suvretta Capital Management opened 41 new positions and closed 25 in Q4 2022.
- Suvretta Capital Management's portfolio value fell 1.1% quarter-over-quarter to $2.38B.
Based on Suvretta Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.